192 related articles for article (PubMed ID: 21511816)
1. Inflammation-associated graft loss in renal transplant recipients.
Dahle DO; Mjøen G; Oqvist B; Scharnagl H; Weihrauch G; Grammer T; März W; Abedini S; Norby GE; Holme I; Fellström B; Jardine A; Holdaas H
Nephrol Dial Transplant; 2011 Nov; 26(11):3756-61. PubMed ID: 21511816
[TBL] [Abstract][Full Text] [Related]
2. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
Svensson M; Dahle DO; Mjøen G; Weihrauch G; Scharnagl H; Dobnig H; März W; Jardine A; Fellström B; Holdaas H
Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
[TBL] [Abstract][Full Text] [Related]
4. Impact of patterns of proteinuria on renal allograft function and survival: a prospective cohort study.
Suhail SM; Kee TS; Woo KT; Tan HK; Yang WS; Chan CM; Foo MW; Li HH; Siddique MM; Wong KS
Clin Transplant; 2011; 25(3):E297-303. PubMed ID: 21362048
[TBL] [Abstract][Full Text] [Related]
5. Graft loss risk in renal transplant recipients with metabolic syndrome: subgroup analyses of the ALERT trial.
Soveri I; Abedini S; Holdaas H; Jardine A; Eriksson N; Fellström B
J Nephrol; 2012; 25(2):245-54. PubMed ID: 21725919
[TBL] [Abstract][Full Text] [Related]
6. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
Fellström B; Abedini S; Holdaas H; Jardine AG; Staffler B; Gimpelewicz C;
Clin Transplant; 2006; 20(6):732-9. PubMed ID: 17100723
[TBL] [Abstract][Full Text] [Related]
7. Macrophage activation is associated with poorer long-term outcomes in renal transplant patients.
Grebe SO; Kuhlmann U; Fogl D; Luyckx VA; Mueller TF
Clin Transplant; 2011; 25(5):744-54. PubMed ID: 20964718
[TBL] [Abstract][Full Text] [Related]
8. Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial.
Fellström B; Holdaas H; Jardine AG; Holme I; Nyberg G; Fauchald P; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Hartmann A; Logan JO; Pedersen TR;
Kidney Int; 2004 Oct; 66(4):1549-55. PubMed ID: 15458450
[TBL] [Abstract][Full Text] [Related]
9. Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study.
Drechsler C; Pihlstrøm H; Meinitzer A; Pilz S; Tomaschitz A; Abedini S; Fellstrom B; Jardine AG; Wanner C; März W; Holdaas H
Transplantation; 2015 Jul; 99(7):1470-6. PubMed ID: 25675199
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2 receptor antibody reduces rejection rates and graft loss in live-donor kidney transplant recipients.
Lim WH; Chang SH; Chadban SJ; Campbell SB; Dent H; Russ GR; McDonald SP
Transplantation; 2009 Nov; 88(10):1208-13. PubMed ID: 19935375
[TBL] [Abstract][Full Text] [Related]
11. Long-term improvement of deceased donor renal allograft survival since 1996: a single transplant center study.
Sola E; Gonzalez-Molina M; Cabello M; Burgos D; Ramos J; Gutierrez C; Lopez V; Soler J; de la Vega E; Hernandez D
Transplantation; 2010 Mar; 89(6):714-20. PubMed ID: 20035250
[TBL] [Abstract][Full Text] [Related]
12. Acute graft pyelonephritis in renal transplant recipients: incidence, risk factors and long-term outcome.
Fiorante S; Fernández-Ruiz M; López-Medrano F; Lizasoain M; Lalueza A; Morales JM; San-Juan R; Andrés A; Otero JR; Aguado JM
Nephrol Dial Transplant; 2011 Mar; 26(3):1065-73. PubMed ID: 20805254
[TBL] [Abstract][Full Text] [Related]
13. Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients.
Oterdoom LH; van Ree RM; de Vries AP; Gansevoort RT; Schouten JP; van Son WJ; Homan van der Heide JJ; Navis G; de Jong PE; Gans RO; Bakker SJ
Transplantation; 2008 Aug; 86(3):391-8. PubMed ID: 18698241
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
[TBL] [Abstract][Full Text] [Related]
15. Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients.
van Ree RM; de Vries AP; Oterdoom LH; The TH; Gansevoort RT; Homan van der Heide JJ; van Son WJ; Ploeg RJ; de Jong PE; Gans RO; Bakker SJ
Nephrol Dial Transplant; 2005 Nov; 20(11):2524-31. PubMed ID: 16115856
[TBL] [Abstract][Full Text] [Related]
16. Doubling of serum creatinine in clinical trials, cost-effectiveness studies, and individual patients: adequate use in renal transplantation.
Gatault P; Al-Najjar A; Barbet C; Roland M; Laouad I; Buchler M; Marlière JF; Métais PE; Clément A; Nivet H; Lebranchu Y; Halimi JM
Transplantation; 2011 Nov; 92(9):1012-7. PubMed ID: 21941225
[TBL] [Abstract][Full Text] [Related]
17. Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.
Soveri I; Holdaas H; Jardine A; Gimpelewicz C; Staffler B; Fellström B
Nephrol Dial Transplant; 2006 Aug; 21(8):2282-9. PubMed ID: 16574686
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study.
Jardine AG; Fellström B; Logan JO; Cole E; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Maes B; Ambühl P; Olsson AG; Pedersen T; Holdaas H
Am J Kidney Dis; 2005 Sep; 46(3):529-36. PubMed ID: 16129216
[TBL] [Abstract][Full Text] [Related]
19. Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery disease.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Nov; 38(9):2895-8. PubMed ID: 17112858
[TBL] [Abstract][Full Text] [Related]
20. Clinical assessment and determinants of chronic allograft nephropathy in maintenance renal transplant patients.
Grinyo JM; Saval N; Campistol JM;
Nephrol Dial Transplant; 2011 Nov; 26(11):3750-5. PubMed ID: 21474575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
